Echo evaluation of PR

Echocardiographic Evaluation of Pulmonary Regurgitation (PR)

---

1. 2D Echocardiography (Structural Assessment)

Assess pulmonary valve morphology (normal, dysplastic, post-surgical, infective)

Evaluate right ventricle (RV):

RV dilatation (chronic PR hallmark)

RV systolic function

Look for:

Dilated main pulmonary artery

Associated congenital lesions (e.g., repaired TOF)

---

2. Color Doppler Assessment

Visualize diastolic regurgitant jet from pulmonary artery → RVOT

Assess:

Jet width

Jet length

Vena contracta width

Severe PR:

Broad jet filling RVOT

Mild PR:

Thin, short jet near valve

---

3. Continuous Wave (CW) Doppler

Key parameters:

Density of signal → dense = severe

Deceleration slope → steep slope = severe PR

Early termination of flow

Pressure Half-Time (PHT)

Short PHT → more severe PR

Typical interpretation:

PHT < 100 ms → Severe PR

100–200 ms → Moderate

> 200 ms → Mild

---

4. Pulsed Wave (PW) Doppler

Sample in main pulmonary artery / branch PAs

Findings:

Diastolic flow reversal

Holodiastolic reversal → severe PR

---

5. Indirect Signs of Severe PR

Marked RV dilatation

Paradoxical septal motion

Dilated pulmonary artery

Reduced RV function (late)

---

6. Quantitative & Supportive Parameters

Vena contracta width

Regurgitant fraction (advanced echo/CMR)

3D echo / CMR (gold standard for RV volumes in chronic PR)

---

7. Common Causes of PR

Post repair of Tetralogy of Fallot (most common)

Pulmonary hypertension (functional PR)

Infective endocarditis

Carcinoid syndrome

Congenital pulmonary valve abnormalities

---

8. Severity Grading (Integrated Approach)

Parameter Mild Moderate Severe

Color jet Small, narrow Intermediate Wide, fills RVOT

CW Doppler Faint Moderate Dense, steep slope

PHT >200 ms 100–200 ms <100 ms

PW Doppler No reversal Brief reversal Holodiastolic reversal

RV size Normal Mild dilatation Marked dilatation

---

Key Takeaway

No single parameter is sufficient → always use an integrated multiparametric approach

Chronic severe PR → RV volume overload → RV dilatation → dysfunction

Comments

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

2025 AHA/ACC Hypertension Guidelines Key points

2025 AHA/ACC Hypertension Guidelines Explained: A Clear Summary for Clinicians and Students Hypertension remains one of the most significant contributors to cardiovascular morbidity and mortality worldwide. With continual refinement of evidence and risk-based strategies, the 2025 AHA/ACC Hypertension Guidelines bring an updated, practical approach that clinicians can use in daily practice. To make learning easier, I’ve created a clean and modern infographic summarizing all major recommendations. You can download it below and use it for study, teaching, or clinical reference. Download Infographic (PNG): 2025 Hypertension Guideline Infographic This post breaks down the key points from the guidelines and complements the infographic for a complete understanding. --- BP Categories: Understanding the Updated Thresholds The guidelines maintain the well-established classification of blood pressure: Normal: <120 / <80 Elevated: 120–129 / <80 Stage 1 Hypertension: 130–139 and/or 8...

Dr. Usman's Cardiology Notes

Search This Blog